Access
To read this story in full you will need to login or make a payment (see right).
Outlook
Nature 449, 160-163 (13 September 2007) | doi:10.1038/449160a; Published online 12 September 2007
nature jobs
Clinical Trial Analyst
- Indegene Lifesystems Pvt. Ltd
- Bengaluru 560 071 India
Associate Scientific Manager / Scientific Manager-Organic / Medicinal Chemistry
- Syngene International
- Bangalore, Karnataka 560099 India
Neglected Diseases A tough transition
Peter A. Singer1, Kathryn Berndtson1, C. Shawn Tracy1, Emma R. M. Cohen1, Hassan Masum1, James V. Lavery2 & Abdallah S. Daar1
Abstract
What is holding back biotechnology in the developing world? Peter A. Singer and his colleagues listen to those on the ground.
The path from basic scientific discovery to effective therapy is rarely rapid or simple, especially in the developing world. Making this transition easier is a sizeable and pressing problem.
To read this story in full you will need to login or make a payment (see right).

